Evidence map›Paper›PMID 41561529›Full record

ArticleEcancermedicalscience2025

Comparison analysis of serum interleukin-6 levels and cervical cancer.

Muisi A Adenekan, Joseph B Minari, Ayodeji Adefemi, Gbenga Olorunfemi, Ayomide I Fayinto, Adebayo Sekumade, Temitope V Adekanye, Adeyemi A Okunowo, Kehinde S Okunade

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Ecancermedicalscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Muisi A AdenekanDepartment of Obstetrics and Gynaecology, Lagos Island Maternity Hospital, Lagos 102273, Nigeria.
Joseph B MinariGenome Editing Research Group, Department of Cell Biology and Genetics, University of Lagos, Lagos 101017, Nigeria.
Ayodeji AdefemiDepartment of Obstetrics and Gynaecology, Lagos State University Teaching Hospital, Lagos 101233, Nigeria.
Gbenga OlorunfemiDivision of Epidemiology and Biostatistics, School of Public Health, University of Witwatersrand, Johannesburg 2193, South Africa.
Ayomide I FayintoDepartment of Obstetrics and Gynaecology, Lagos University Teaching Hospital, Lagos 102215, Nigeria.
Adebayo SekumadeDepartment of Obstetrics and Gynaecology, Lagos University Teaching Hospital, Lagos 102215, Nigeria.
Temitope V AdekanyeDepartment of Obstetrics and Gynaecology, Lagos University Teaching Hospital, Lagos 102215, Nigeria.
Adeyemi A OkunowoDepartment of Obstetrics and Gynaecology, Lagos University Teaching Hospital, Lagos 102215, Nigeria.
Kehinde S OkunadeDepartment of Obstetrics and Gynaecology, Lagos University Teaching Hospital, Lagos 102215, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synopsis: We found a significant increase in serum IL-6 levels of 214.9 ng/mL (95% CI: 60.1-369.7, Objectives: Despite growing evidence of the role of interleukin-6 ( Methods: We conducted a cross-sectional study among women with and without CC in two hospitals. A venous blood sample was collected from each participant for laboratory analysis of serum Results: Our study found a significant unit increase of 214.9 ng/mL (95%CI: 60.1-369.7, Conclusion: Our study findings highlight the potential utility of serum

Indexed as

cervical cancerinflammationinterleukin-6Nigeriaprognosis

Identifiers

PMID41561529
PMCPMC12812805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.